CLINICAL-PREDICTION RULES TO OPTIMIZE CYTOTOXIN TESTING FOR CLOSTRIDIUM-DIFFICILE IN HOSPITALIZED-PATIENTS WITH DIARRHEA

Citation
Da. Katz et al., CLINICAL-PREDICTION RULES TO OPTIMIZE CYTOTOXIN TESTING FOR CLOSTRIDIUM-DIFFICILE IN HOSPITALIZED-PATIENTS WITH DIARRHEA, The American journal of medicine, 100(5), 1996, pp. 487-495
Citations number
49
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00029343
Volume
100
Issue
5
Year of publication
1996
Pages
487 - 495
Database
ISI
SICI code
0002-9343(1996)100:5<487:CRTOCT>2.0.ZU;2-P
Abstract
BACKGROUND: Although routine testing of hospitalized patients with dia rrhea for Clostridium difficile cytotoxin has been advocated as a high -yield procedure, the rationale for this practice has been questioned. To target a low-yield subgroup for whom routine testing could be defe rred, we derived a clinical decision rule for predicting results of th e C difficile cytotoxin assay in hospitalized adults with diarrhea. ME THODS: We hypothesized a priori that two variables, antibiotic use (wi thin 30 days prior to testing) and history of significant diarrhea (ne w onset of >3 partially formed or watery stools per 24 hour period), w ould be highly predictive of cytotoxin results, and obtained these dat a on 480 consecutive patients who underwent diagnostic testing for C d ifficile at a university hospital and affiliated Veterans Affairs medi cal center. For more detailed modelling, we recorded symptoms, signs, comorbidity, and other potential causes of diarrhea for 68 test positi ve patients (cases) and 265 randomly selected test negative patients ( controls) within the study cohort. RESULTS: The overall prevalence of positive cytotoxin assays was 14%. Prior antibiotic therapy (OR = 9.0, 95% CI 2.1-38.4), significant diarrhea (OR = 2.2, 95% CI 1.1-4.7), an d abdominal pain (OR = 1.9, 95% CI 0.96-3.7) were independent predicto rs of cytotoxin assay results. The model discriminated patients with p ositive and negative assays with a receiver operating characteristic ( ROC) area of 0.68; observed and predicted probabilities of a positive cytotoxin assay were well correlated over the entire range of observed probabilities (r(2) = 0.86). A decision rule (defined as positive if prior antibiotic use and either significant diarrhea or abdominal pain are present) demonstrated sensitivity and specificity of 86 and 45%. When applied to the entire dataset (N = 480), a simplified a priori ru le, defined as positive if both prior antibiotic use and history of si gnificant diarrhea are present, demonstrated sensitivity, specificity, positive and negative predictive value of 80, 45, 18 and 94%, respect ively (6% of those predicted to be cytotoxin-negative actually tested positive). Use of this rule would have averted 39% of cytotoxin assays in our study population. CONCLUSIONS: Patients without prior antibiot ic use and either significant diarrhea or abdominal pain are unlikely to have positive C difficile cytotoxin assay results, and may not rout inely require cytotoxin testing.